A Phase 1, Open-Label, 2-Period, 2-Formulation, Within-Subject Crossover Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects Under Fasting Conditions.
Latest Information Update: 16 Jan 2026
At a glance
Most Recent Events
- 07 Jan 2026 Planned End Date changed from 14 Jul 2025 to 31 Mar 2026.
- 07 Jan 2026 Planned primary completion date changed to 31 Mar 2026.
- 07 Jan 2026 Status changed from completed to recruiting.